Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950129-04-001318
Filing Date
2004-03-15
Accepted
2004-03-15 16:31:25
Documents
7
Period of Report
2003-12-31

Document Format Files

Seq Description Document Type Size
1 ENCYSIVE PHARMACEUTICALS INC.- DECEMBER 31, 2003 h13494e10vk.txt 10-K 314665
3 SUBSIDIARIES OF THE REGISTRANT h13494exv21w1.txt EX-21.1 600
4 CONSENT OF KPMG LLP - HOUSTON, TEXAS h13494exv23w1.txt EX-23.1 1002
5 CERTIFICATION OF CEO PURSUANT TO SECTION 302 h13494exv31w1.txt EX-31.1 3461
6 CERTIFICATION OF CFO PURSUANT TO SECTION 302 h13494exv31w2.txt EX-31.2 3481
7 CERTIFICATION OF CEO PURSUANT TO SECTION 906 h13494exv32w1.txt EX-32.1 1437
8 CERTIFICATION OF CFO PURSUANT TO SECTION 906 h13494exv32w2.txt EX-32.2 1488
  Complete submission text file 0000950129-04-001318.txt   328551
Mailing Address
Business Address 6700 WEST LOOP SOUTH 4TH FLOOR BELLAIRE TX 77401 7137968822
ENCYSIVE PHARMACEUTICALS INC (Filer) CIK: 0000887023 (see all company filings)

EIN.: 133532643 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-20117 | Film No.: 04669926
SIC: 2834 Pharmaceutical Preparations